Patient Experience

A 28-year-old tribal woman from a...
May 13, 2025

A 28-year-old tribal woman from a remote village presented with advanced cervical cancer after years of avoiding medical care due to cultural beliefs. Dr. Sasikumari arranged for an interpreter from her community and involved tribal elders in treatment discussions. She performed radical hysterectomy with ovarian transposition to preserve hormonal function, followed by tailored chemoradiation. The patient returned to her village as a health advocate, encouraging other women to seek screening.

A 45-year-old corporate executive with BRCA1...
May 12, 2025

A 45-year-old corporate executive with BRCA1 mutation developed primary peritoneal carcinoma despite prophylactic measures. Dr. Sasikumari implemented hyperthermic intraperitoneal chemotherapy (HIPEC) following cytoreductive surgery, a novel approach at their facility. The patient experienced prolonged recovery but achieved complete remission, returning to her leadership position while becoming a genetic counseling volunteer. (Patient of Dr. M.)

A 62-year-old retired schoolteacher with multiple...
May 02, 2025

A 62-year-old retired schoolteacher with multiple comorbidities presented with recurrent endometrial cancer. Dr. Sasikumari coordinated with cardiology and endocrinology to optimize her for surgery, then performed robotic-assisted hysterectomy with sentinel lymph node mapping. The minimal approach allowed rapid recovery despite her complex medical history, enabling her to resume volunteering at local literacy programs. (Patient of Dr. M.)

A 34-year-old transgender man on testosterone...
May 18, 2025

A 34-year-old transgender man on testosterone therapy developed ovarian cancer while preserving fertility options. Dr. Sasikumari worked with his mental health team and performed fertility-sparing surgery with oocyte cryopreservation before completing cancer treatment. The patient maintained gender-affirming care throughout while achieving cancer remission. (Patient of Dr. M.)

A 51-year-old construction worker with vulvar...
Apr 29, 2025

A 51-year-old construction worker with vulvar melanoma presented with advanced disease. Dr. Sasikumari employed wide local excision with groin sentinel node biopsy followed by immunotherapy instead of traditional radiation. The innovative approach resulted in complete response despite initial poor prognosis, allowing her to return to modified work duties. (Patient of Dr. M.)

An 18-year-old college student with rare...
May 04, 2025

An 18-year-old college student with rare Sertoli-Leydig cell tumor presented with virilization symptoms. Dr. Sasikumari performed fertility-preserving unilateral oophorectomy with careful endocrine monitoring. The patient's masculinizing features reversed post-surgery, and she resumed normal pubertal development while maintaining reproductive potential. (Patient of Dr. M.)

A 70-year-old grandmother with recurrent uterine...
Apr 23, 2025

A 70-year-old grandmother with recurrent uterine sarcoma participated in a clinical trial coordinated by Dr. Sasikumari. The targeted therapy caused unexpected side effects, requiring frequent dose adjustments and supportive care. Though the cancer eventually progressed, the patient contributed valuable data while maintaining quality life for 18 additional months with family. (Patient of Dr. M.)

A 39-year-old refugee from conflict zone...
May 06, 2025

A 39-year-old refugee from conflict zone presented with advanced ovarian cancer and severe malnutrition. Dr. Sasikumari collaborated with nutritionists and social workers to build her health before interval debulking surgery. The patient achieved optimal cytoreduction and responded well to chemotherapy, eventually reuniting with her children through refugee resettlement programs. (Patient of Dr. M.)

A 57-year-old farmer with chemotherapy-resistant gestational...
May 06, 2025

A 57-year-old farmer with chemotherapy-resistant gestational trophoblastic neoplasia required salvage therapy. Dr. Sasikumari utilized high-dose chemotherapy with stem cell rescue, managing complex toxicities through meticulous inpatient care. The aggressive approach resulted in durable remission, allowing her to return to agricultural work. (Patient of Dr. M.)

A 31-year-old software engineer with Lynch...
Apr 19, 2025

A 31-year-old software engineer with Lynch syndrome developed synchronous endometrial and ovarian cancers. Dr. Sasikumari performed simultaneous resection via minimally invasive approach and implemented comprehensive surveillance protocol for her genetic condition. The patient resumed her career while participating in Lynch syndrome advocacy networks. (Patient of Dr. M.)

A 48-year-old classical dancer with vaginal...
May 04, 2025

A 48-year-old classical dancer with vaginal rhabdomyosarcoma faced potential loss of pelvic function. Dr. Sasikumari employed organ-preserving resection with intraoperative radiation therapy, collaborating with rehabilitation specialists. The patient regained near-normal function and returned to performing, adapting her choreography as needed. (Patient of Dr. M.)

A 65-year-old retired nurse with carcinosarcoma...
Apr 19, 2025

A 65-year-old retired nurse with carcinosarcoma presented with pulmonary metastases. Dr. Sasikumari combined cytoreductive surgery with combination immunotherapy, managing immune-related adverse events through close monitoring. The unconventional approach yielded partial response, providing extended survival with maintained cognitive function. (Patient of Dr. M.)

A 42-year-old single mother with cervical...
Apr 20, 2025

A 42-year-old single mother with cervical cancer recurrence after prior treatment sought fertility preservation. Dr. Sasikumari performed radical trachelectomy with neoadjuvant chemotherapy, enabling cancer control while preserving uterine function. The patient later successfully carried a pregnancy via surrogacy using her cryopreserved oocytes. (Patient of Dr. M.)

A 53-year-old restaurant owner with fallopian...
May 04, 2025

A 53-year-old restaurant owner with fallopian tube cancer developed platinum allergy during treatment. Dr. Sasikumari switched to liposomal doxorubicin and bevacizumab maintenance, carefully managing hypersensitivity reactions. The alternative regimen provided prolonged disease control while allowing her to continue managing her business. (Patient of Dr. M.)

Know More

Icon
Location

VO-284, Eldeco Centre 110017